AdipoGen Life Sciences

anti-Pyrin (human), pAb (AL196)

CHF 420.00
In stock
AG-25B-0020-C100100 µgCHF 420.00
More Information
Product Details
Synonyms Marenostrin; MEFV; TRIM20
Product Type Polyclonal Antibody
Properties
Source/Host Rabbit
Immunogen/Antigen Synthetic peptide corresponding to aa 2-29 (A2KTPSDHLLSTLEELVPYDFEKFKFKLQ29) of human pyrin.
Application

Immunoprecipitation: (1:100)
Western Blot: (1:500)

Crossreactivity Human
Specificity

Recognizes human pyrin.

Purity Epitope-affinity purified.
Concentration 1mg/ml
Formulation Liquid. In PBS containing 10% glycerol and 0.02% sodium azide.
Isotype Negative Control

Rabbit IgG

Accession Number O15553
Shipping and Handling
Shipping BLUE ICE
Short Term Storage +4°C
Long Term Storage -20°C
Handling Advice After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/Stability Stable for at least 1 year after receipt when stored at -20°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description

Pyrin regulates inflammation by interacting with the cytoskeleton. Pyrin may direct the migration of white blood cells to sites of inflammation and stop or slow the inflammatory response when it is no longer needed. Defects in pyrin are the cause for Mediterranean fever.

Product References
  1. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing: S. Papin, et al.; Cell Death Differ. 14, 1457 (2007)
  2. Familial autoinflammation with neutrophilic dermatosis reveals a regulatory mechanism of pyrin activation: S.L. Masters, et al., Sci. Transl. Med. 8, 332ra45 (2016)
  3. A novel Pyrin-Associated Autoinflammation with Neutrophilic Dermatosis mutation further defines 14-3-3 binding of Pyrin and distinction to Familial Mediterranean Fever: F. Moghaddas, et al.; Ann. Rheum.Dis. 76, 2085 (2017)
  4. Lack of Protein Prenylation Promotes Nlrp3 Inflammasome Assembly in Human Monocytes: O.P. Skinner, et al.; J. Allergy Clin. Immunol. 143, 2315 (2019) [KO validation]
  5. Pyrin dephosphorylation is sufficient to trigger inflammasome activation in familial Mediterranean fever patients: F. Magnotti, et al.; EMBO Mol. Med. 11, e10547 (2019)
  6. Statins repress needle-like carbon nanotube- or cholesterol crystal-stimulated IL-1β production by inhibiting the uptake of crystals by macrophages: H. Cui, et al.; Biochem. Pharmacol. 188, 114580 (2021)
  7. Mutations in the B30.2 and the central helical scaffold domains of pyrin differentially affect inflammasome activation: D. Chirita, et al.; Cell Death Dis. 14, 213 (2023)
  8. Gain-of-function of MEFV Mutation Causes Very Early Onset Inflammatory Bowel Disease: Q. Wang, et al.; J. Clin. Immunol. ahead of print (2023)
  9. A dominant pathogenic MEFV mutation causes atypical pyrin-associated periodic syndromes: Q. Wang, et al.; JCI Insight 8, e172975 (2023)
  10. Pyrin variant E148Q potentiates inflammasome activation and the effect of pathogenic mutations in cis: T. Reygaerts, et al.; Rheumatology, ahead of print (2023)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.